rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Roger Garceau

Director

Company insider

Files Form 4 as: Director, Protara Therapeutics; Director, Entera Bio; SVP & Cmo, Nps Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
73
Buys
0
Sells
2
Bought
$0
Sold
$4.1M
Companies
3
Companies where not an officer
2
First trade
11 Dec 2008
Last trade
15 Jun 2026
Last filed
16 Jun 2026

Companies traded

Where they are an officer
Nps PharmaceuticalsOfficer · last 21 Feb 20150 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TARA Protara TherapeuticsDirector · Biotechnology · last 15 Jun 20260 buys · 0 sells
ENTX Entera BioDirector · Biotechnology · last 1 Jan 20240 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jun 2026filed 16 Jun 2026TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
15 Jun 2026filed 16 Jun 2026TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
12 Jun 2025filed 13 Jun 2025TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—24,000 at $0.00filing
7 Jun 2024filed 10 Jun 2024TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
1 Jan 2024filed 3 Jan 2024ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—108,333 at $0.00filing
7 Jun 2023filed 8 Jun 2023TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
2 Jan 2023filed 4 Jan 2023ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—89,041 at $0.00filing
8 Jun 2022filed 9 Jun 2022TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
1 Jan 2022filed 11 Jan 2022ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—35,852 at $0.00filing
1 Jan 2022filed 11 Jan 2022ENTX Entera Biooption or derivative · BiotechnologySEC FORM 4 Code A—107,557 at $0.00filing
9 Jun 2021filed 10 Jun 2021TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
9 Jun 2020filed 11 Jun 2020TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—9,000 at $0.00filing
10 Jan 2020filed 13 Jan 2020TARA Protara TherapeuticsBiotechnologySEC FORM 4 Code A—33,000 at $0.00filing
9 Jan 2020filed 11 Jun 2020TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,399filing
9 Jan 2020filed 13 Jan 2020TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,399filing
9 Jan 2020filed 13 Jan 2020TARA Protara Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—10,491filing
21 Feb 2015filed 24 Feb 2015Nps PharmaceuticalsSEC FORM 4 Code U$2.0M43,349 at $46.00filing
21 Feb 2015filed 24 Feb 2015Nps Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—30,615filing
21 Feb 2015filed 24 Feb 2015Nps Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—84,941filing
21 Feb 2015filed 24 Feb 2015Nps Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—9,900filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed2

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.